{"ORPHApacket":[{"ORPHApacketID":"514","date":"2019-12-06 08:20:13","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"514","Name":[{"lang":"en","label":"Acute monoblastic leukemia"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_514","DisorderType":[{"Name":[{"lang":"en","label":"Disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377788"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Unclassified acute myeloid leukemia"}],"ORPHA":"167714","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_167714"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"Acute monoblastic leukemia (AML-M5), is one of the most common subtypes of acute myeloid leukemia (AML; see this term) that is either comprised of more than 80% of monoblasts (AML-M5a) or 30-80% monoblasts with (pro)monocytic differentiation (AML-M5b). AML-M5 presents with asthenia, pallor, fever, and dizziness. Specific features of AML-M5 include hyperleukocytosis, propensity for extramedullary infiltrates, coagulation abnormalities including disseminated intravascular coagulation and neurological disorders. Leukemia cutis and gingival infiltration can also be seen. A characteristic translocation observed in AML-M5 is t(9;11)."}],"AverageAgeOfOnsetList":[{"count":"1","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"Childhood"}]}]}],"TypeOfInheritanceList":[{"count":"1","TypeOfInheritance":[{"Name":[{"lang":"en","label":"Not applicable"}]}]}],"SynonymList":[{"count":"2","Synonym":[{"lang":"en","label":"AML M5"},{"lang":"en","label":"Acute monocytic leukemia"}]}],"HPODisorderAssociationList":[{"count":"20","HPODisorderAssociation":[{"HPOId":"HP:0004845","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0004845","HPOTerm":"Acute monocytic leukemia","HPOFrequency":[{"ORPHA":"453310","Name":[{"lang":"en","label":"Obligate (100%)"}]}]},{"HPOId":"HP:0001903","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0001903","HPOTerm":"Anemia","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0001974","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0001974","HPOTerm":"Leukocytosis","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0002875","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0002875","HPOTerm":"Exertional dyspnea","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0012378","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0012378","HPOTerm":"Fatigue","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0031020","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0031020","HPOTerm":"Bone marrow hypercellularity","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0100827","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0100827","HPOTerm":"Lymphocytosis","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0001482","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0001482","HPOTerm":"Subcutaneous nodule","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0001730","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0001730","HPOTerm":"Progressive hearing impairment","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0001785","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0001785","HPOTerm":"Ankle swelling","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0001824","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0001824","HPOTerm":"Weight loss","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0001931","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0001931","HPOTerm":"Hypochromic anemia","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0001945","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0001945","HPOTerm":"Fever","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0002039","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0002039","HPOTerm":"Anorexia","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0011787","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0011787","HPOTerm":"Central hypothyroidism","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0012145","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0012145","HPOTerm":"Abnormality of multiple cell lineages in the bone marrow","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0025289","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0025289","HPOTerm":"Cervical lymphadenopathy","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0025435","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0025435","HPOTerm":"Increased lactate dehydrogenase activity","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0100520","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0100520","HPOTerm":"Oliguria","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0100539","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0100539","HPOTerm":"Periorbital edema","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]}]}],"HPODisorderSetStatus":[{"ValidationStatus":"y"}]}]}